Transaction in Own Shares

Summary by AI BETAClose X

Helios Underwriting Plc has purchased 15,577 of its ordinary shares between July 6th and July 10th, 2026, at prices ranging from 218.50p to 219.00p, with a weighted average price of 218.76p per share. These shares will be held in treasury, resulting in 76,040,011 ordinary shares in issue, of which 5,945,159 will be held in treasury. The company has also stated that shareholders can use the figure of 70,094,852 as the denominator for calculating notification requirements under the FCA's Disclosure Guidance and Transparency Rules.

Disclaimer*

Helios Underwriting Plc
13 July 2026
 

 13 July 2026
 HELIOS UNDERWRITING PLC
 ("Helios ", or the "Company")
 Transaction in Own Shares

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, announces it has purchased the following number of its Ordinary shares of 10p each through Peel Hunt LLP.

Date of purchase

06 July 2026 - 10 July 2026

Number of ordinary shares purchased:

15,577

Lowest price per share (pence):

218.50

Highest price per share (pence):

219.00

Weighted average price per day (pence):

218.76

The Company intends to place the purchased shares into Treasury.

Following the settlement of the purchased shares, the Company will have 76,040,011 Ordinary shares in issue of which 5,945,159 are held in Treasury.

The figure of 70,094,852 may be used by shareholders as the denominator for calculating whether they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

The table below contains detailed information about the purchases made as part of the buyback programme which was announced by the Company on 09 April 2026 (the "Programme").

 Aggregate information:

Venue

Volume Weighted Average Price (p)

Aggregated Volume

Lowest price paid per share (p)

Highest price paid per share (p)

AIMX

218.76

15,577

218.5

219.00

 
 Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of the Market Abuse Regulation (EU) No 596/2014 as it forms part of UK law, a full breakdown of the individual trades made by Peel Hunt on behalf of the Company as part of the Programme is detailed below:

Number of shares purchased

Transaction price (pence)

Venue

Date

Time of each trade

Transaction Reference Number

2,200

219.00

AIMX

06-07-2026

13:41:36

00196420546TRLO1

5,932

219.00

AIMX

06-07-2026

14:14:46

00196422428TRLO1

7,445

218.5

AIMX

10-07-2026

14:43:29

00127627856ORLO1

 
 For further information contact:

Helios Underwriting plc

 

Louis Tucker - Chief Executive Officer

+44 (0)20 3965 6441

Adhiraj Maitra - Director of Finance and Operations

+44 (0)20 3743 2114

Peel Hunt (Nomad, Broker and Financial Adviser)

 

Dan Webster / Andrew Buchanan / Martin Frowde

+44 (0)20 7418 8900

Singer Capital Markets (Joint Broker)

 

Charles Leigh-Pemberton / Russell Cook / James Todd

+44 (0)20 7496 3000

FTI Consulting

 

Ed Berry

+44 (0)7703 330 199

Christian Harte

+44 (0)7974 288 763

 
 About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings